Tissue Retention Time
Tissue Retention Time is a pharmacokinetic parameter that denotes the duration a pharmacologically active agent remains in ocular tissue at therapeutic concentrations following administration, distinguishing it from systemic clearance metrics by emphasizing localized residence and sustained ocular bioavailability.
130
Publications
5.7K
Citations
583
Authors
197
Institutions
Publications per year
2017–2026
13
Parents
130
Greg White, Wendell A. Gibby, Michael F. Tweedle · Investigative Radiology · 2006 · 362 citations
Medicine, Nuclear Medicine, Surgery +11
Wendell A. Gibby, Krissa A. Gibby, Wendell A. Gibby · Investigative Radiology · 2004 · 226 citations
1–5 of 130
583
University of California, San Francisco, United States
4 publications · 354 citations
4
h-index
University of California, San Francisco, United States
3 publications · 301 citations
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 583
197

Centre National de la Recherche Scientifique
Paris, France
3 h-index
14 publications
510 citations
Neurological Surgery
Rockville Centre, United States
3 h-index
16 publications
1.8K citations
University of California, San Francisco
San Francisco, United States
3 h-index
13 publications
1.1K citations

University of Rochester
Rochester, United States
3 h-index
8 publications
257 citations
University of Michigan
Ann Arbor, United States
3 h-index
17 publications
472 citations
Inserm
Paris, France
2 h-index
9 publications
394 citations
University of Utah
Salt Lake City, United States
2 h-index
13 publications
364 citations

University of British Columbia
Vancouver, Canada
2 h-index
4 publications
117 citations
1–8 of 197
Repository · 14 publications · 548 citations
13
h-index
5 publications · 109 citations
5
h-index
4 publications · 187 citations
4
h-index
JN · 4 publications · 264 citations
4
h-index
4 publications · 109 citations
4
h-index
1–5